Description
Vanta Bioscience Limited has listed 8,00,000 new equity shares issued on preferential basis to promoters, with trading commencing October 17, 2025.
Summary
Vanta Bioscience Limited (Scrip Code: 540729) has listed 8,00,000 new equity shares of Rs. 10/- each issued at a premium of Rs. 40/- on a preferential basis to promoters. The shares will be available for trading on BSE from October 17, 2025, and are subject to a lock-in period until April 29, 2027.
Key Points
- 8,00,000 equity shares issued at Rs. 50/- per share (Rs. 10/- face value + Rs. 40/- premium)
- Allotment made on May 6, 2025 to promoters on preferential basis
- New shares rank pari-passu with existing equity shares
- Distribution numbers: 6312001 to 7112000
- ISIN: INE695X01011
- All 8,00,000 shares subject to lock-in until April 29, 2027
Regulatory Changes
No regulatory changes introduced by this circular.
Compliance Requirements
- Trading members are informed of the new securities listing
- Shares cannot be traded by promoters until the lock-in period expires on April 29, 2027
Important Dates
- Allotment Date: May 6, 2025
- Trading Commencement: October 17, 2025
- Lock-in Expiry: April 29, 2027
Impact Assessment
This is a routine corporate action with minimal market impact. The preferential allotment to promoters increases the paid-up capital of Vanta Bioscience Limited. However, since all new shares are locked-in for approximately 18 months from the notice date, there will be no immediate increase in tradable float. The issuance demonstrates promoter confidence and capital infusion into the company.
Impact Justification
Routine preferential allotment to promoters with standard lock-in period. Limited market impact due to promoter-only issuance and lock-in restrictions.